Granite Point Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-75,000
| Closed | -$818K | – | 94 |
|
|
2016
Q4 | $818K | Buy |
+75,000
| New | +$818K | 0.65% | 48 |
|
|
2016
Q3 | – | Sell |
-327,579
| Closed | -$2.3M | – | 100 |
|
|
2016
Q2 | $2.3M | Buy |
+327,579
| New | +$2.3M | 0.99% | 13 |
|
|
2015
Q4 | – | Sell |
-35,432
| Closed | -$946K | – | 93 |
|
|
2015
Q3 | $946K | Sell |
35,432
-1,036
| -3% | -$27.7K | 0.65% | 37 |
|
|
2015
Q2 | $1.76M | Buy |
36,468
+16,468
| +82% | +$793K | 0.51% | 24 |
|
|
2015
Q1 | $1.22M | Sell |
20,000
-53,000
| -73% | -$3.23M | 0.45% | 34 |
|
|
2014
Q4 | $3.78M | Buy |
73,000
+56,800
| +351% | +$2.94M | 1.77% | 6 |
|
|
2014
Q3 | $713K | Buy |
+16,200
| New | +$713K | 0.36% | 47 |
|
|
2014
Q1 | – | Sell |
-50,000
| Closed | -$849K | – | 109 |
|
|
2013
Q4 | $849K | Buy |
+50,000
| New | +$849K | 0.14% | 64 |
|